Search

Your search keyword '"Yende-Zuma, Nonhlanhla"' showing total 346 results

Search Constraints

Start Over You searched for: Author "Yende-Zuma, Nonhlanhla" Remove constraint Author: "Yende-Zuma, Nonhlanhla"
346 results on '"Yende-Zuma, Nonhlanhla"'

Search Results

2. Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population.

8. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

11. Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa

12. A cluster-randomized controlled trial to improve the quality of integrated HIV-tuberculosis services in primary health care clinics in South Africa

14. Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa

15. HIV treatment outcomes among people with initiation CD4 counts >500 cells/[micro]L after implementation of Treat All in South African public clinics: a retrospective cohort study

16. Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort.

17. SARS-CoV-2 seropositivity and risk factors in African women living with HIV and their Infants

18. Integrated provision of topical pre-exposure prophylaxis in routine family planning services in South Africa: a non-inferiority randomized controlled trial

24. Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis.

26. Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women

27. A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis

28. Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes

31. INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial

34. Impact of Motivational Enhanced Adherence Counseling and Point-of-Care Viral Load Monitoring on Viral Load Outcome in Women on Life-Long ART: A Randomized Pilot Study

38. Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

42. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

43. Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention

44. Additional file 1 of Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control

45. Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa

48. A Quality Improvement Intervention to Inform Scale-Up of Integrated HIV-TB Services: Lessons Learned From KwaZulu-Natal, South Africa

49. A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis

50. A cluster‐randomized controlled trial to improve the quality of integrated HIV‐tuberculosis services in primary healthcareclinics in South Africa

Catalog

Books, media, physical & digital resources